+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Oxidative Stress Assay Market by Product & Service (Consumables, Instruments, Services), Test Type (Antioxidant Capacity Assays, Enzyme-Based Assays, Indirect Assays), Technology, End-user, Indication - Forecast 2023-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336585
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Oxidative Stress Assay Market size was estimated at USD 961.61 million in 2022, USD 1,064.53 million in 2023, and is expected to grow at a CAGR of 10.83% to reach USD 2,190.56 million by 2030.

The oxidative stress assay is a bioanalytical method to evaluate the balance between reactive oxygen species (ROS) production and the antioxidant defense mechanisms within biological systems. These assays are essential for understanding oxidative stress's role in cellular processes, disease progression, and treatment efficacy. Oxidative stress assay is crucial in understanding oxidative stress, a significant contributor to pathological conditions such as neurodegenerative diseases, cardiovascular disorders, cancer, and aging processes. The constant generation of ROS through cellular metabolic activities and their interaction with cellular components cause harm to proteins, nucleic acids, and lipids, leading to cell dysfunction or cell death, significantly increasing the need for oxidative stress assays. Moreover, the rising prevalence of chronic diseases associated with oxidative stress has increased the demand for robust diagnostic tools that enable early detection and treatment guidance. However, high costs associated with advanced diagnostic technologies and the lack of standardized protocols across various assay platforms result in inconsistent results, significantly impeding the adoption of oxidative stress assays. In addition, the growing demand for in vitro diagnostics and point-of-care testing technologies presents a vast potential for expanding the application of oxidative stress assays in clinical settings. Developing portable, easy-to-use devices integrated with advanced detection systems can streamline early diagnosis and enable faster therapeutic interventions. Combining machine learning algorithms and artificial intelligence (AI) into these assay platforms facilitates a greater understanding of complex disease mechanisms and helps identify novel therapeutic targets.

Regional Insights

In the Americas region, increased awareness and research on reactive oxygen species (ROS), the rising prevalence of chronic diseases, and growing investments in developing advanced oxidative stress assays have raised the adoption of oxidative stress assays in the region. Various academic institutions have extensively studied oxidative stress in disease progression and aging. The presence of manufacturers such as Thermo Fisher Scientific, Inc. and Merck KGaA focus on collaboration activities to expand its mass spectrometry portfolio, thereby strengthening its position in the oxidative stress assay market. The Asia-Pacific (APAC) region witnessed rapid oxidative stress assay market growth due to expansive economic development across emerging nations such as India and China. China and Japan have established themselves as key players in the oxidative stress assay market with strong R&D investments and the presence of key manufacturers such as Abnova Corporation and Fujifilm Wako Pure Chemical Corporation. Europe’s oxidative stress assay market significantly developed in the EMEA region due to its strong presence of pharmaceutical and biotechnology companies and government funding for research projects. The European Union (EU) countries actively invest in oxidative stress assay development due to the rising incidences of chronic disorders and an aging population. Regulatory harmonization across EU member states has enabled a streamlined approach towards product approvals and innovation support. The Middle East is witnessing significant growth due to improving healthcare infrastructure, while Africa's emerging focus on non-communicable diseases presents opportunities for future market expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Oxidative Stress Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oxidative Stress Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Oxidative Stress Assay Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agilent Technologies, Inc., AMS Biotechnology, Arbor Assays Inc., Assay Genie, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioAssay Systems, Biomedica Medizinprodukte GmbH, BPS Bioscience, Inc., Callegari Srl, Cayman Chemical Company, Cell Biolabs, Inc., Cytek Biosciences, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Ethos Biosciences, Inc., Geno Technology Inc., Genox Corporation, Helvetica Health Care Sàrl, Hycult Biotech Inc., Kamiya Biomedical Company, Labstat Inc., Merck KGaA, Oxford Biomedical Research, Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Vivid Microscopy, LLC, and ZenBio, Inc.

Market Segmentation & Coverage

This research report categorizes the Oxidative Stress Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Consumables
      • Kits
      • Reagents
    • Instruments
    • Services
  • Test Type
    • Antioxidant Capacity Assays
    • Enzyme-Based Assays
    • Indirect Assays
    • Reactive Oxygen Species-Based Assays
  • Technology
    • Chromatography
    • Enzyme-linked Immunosorbent Assay
    • Flow Cytometry
    • High-Content Screening
    • Label-Free Detection
    • Microscopy
  • End-user
    • Academic Research Institutes
    • Clinical Laboratories
    • Contract Research Organizations
    • Pharmaceutical and Biotechnology Companies
  • Indication
    • Cancer
    • Cardiovascular Diseases
    • Diabetes
    • Respiratory Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Oxidative Stress Assay Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oxidative Stress Assay Market?
  3. What are the technology trends and regulatory frameworks in the Oxidative Stress Assay Market?
  4. What is the market share of the leading vendors in the Oxidative Stress Assay Market?
  5. Which modes and strategic moves are suitable for entering the Oxidative Stress Assay Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Oxidative Stress Assay Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industries
5.1.1.2. Rising incidence of various cellular diseases across the globe
5.1.1.3. Increasing applications of oxidative stress measurement in the cosmetic skincare industry
5.1.2. Restraints
5.1.2.1. High cost of instruments of oxidative stress assay
5.1.3. Opportunities
5.1.3.1. Technological advancement in high-content screening for drug discovery
5.1.3.2. Emergence of novel in vitro model of oxidative stress
5.1.4. Challenges
5.1.4.1. Lack of trained personnel for emerging technologies
5.2. Market Segmentation Analysis
5.2.1. Product & Service: Rising demand for consumables across end-use sectors
5.2.2. Test Type: Increasing demand for antioxidant capacity assays
5.2.3. Technology: Emerging popularity of Enzyme-linked Immunosorbent Assay (ELISA)
5.2.4. End-user: Penetration of oxidative-stress-assay in pharmaceutical and biotechnology companies
5.2.5. Indication: Expanding use of oxidative-stress-assay for detecting respiratory diseases
5.3. Market Trend Analysis
5.3.1. Presence of well-established universities and increasing research activities for oxidative stress assay in the Americas.
5.3.2. Rising emphasis on research and expenditure in biotechnology and pharmaceutical industries, supporting the market growth in Asia-Pacific region.
5.3.3. Strong government support for oxidative stress assay development and collaborations with academic institutions in the EMEA region.
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Oxidative Stress Assay Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3.1. Kits
6.3.2. Reagents
6.3. Instruments
6.4. Services
7. Oxidative Stress Assay Market, by Test Type
7.1. Introduction
7.2. Antioxidant Capacity Assays
7.3. Enzyme-Based Assays
7.4. Indirect Assays
7.5. Reactive Oxygen Species-Based Assays
8. Oxidative Stress Assay Market, by Technology
8.1. Introduction
8.2. Chromatography
8.3. Enzyme-linked Immunosorbent Assay
8.4. Flow Cytometry
8.5. High-Content Screening
8.6. Label-Free Detection
8.7. Microscopy
9. Oxidative Stress Assay Market, by End-user
9.1. Introduction
9.2. Academic Research Institutes
9.3. Clinical Laboratories
9.4. Contract Research Organizations
9.5. Pharmaceutical and Biotechnology Companies
10. Oxidative Stress Assay Market, by Indication
10.1. Introduction
10.2. Cancer
10.3. Cardiovascular Diseases
10.4. Diabetes
10.5. Respiratory Diseases
11. Americas Oxidative Stress Assay Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Oxidative Stress Assay Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Oxidative Stress Assay Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Biogen to Acquire Reata Pharmaceuticals
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Labstat Inc., A Certified Group Company, Partners With Toxys to Offer ToxTracker Assay
14.3.2.2. IIVS and Toxys Enter into Agreement to Offer ToxTracker for In Vitro Genetic Toxicity Evaluation
14.3.3. New Product Launch & Enhancement
14.3.3.1. Next-Generation Proximity Ligation-Based Assays Advance Spatial Proteomics with Precision & Reliability
14.3.3.2. Indian Scientists Discover Blood Test To Identify Risk Of Alzheimer’s Disease
14.3.3.3. Roundup: New Breath Test In Singapore Analyses Fat Burning And More Briefs
14.3.3.4. OxiDx Launched To Maximize Oxidative Stress Technology
14.3.4. Investment & Funding
14.3.4.1. New USDA Grant Supports MSU Researcher Studying Prevention Of Dairy Cow Diseases After Calving
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abcam PLC
15.1.2. Agilent Technologies, Inc.
15.1.3. AMS Biotechnology
15.1.4. Arbor Assays Inc.
15.1.5. Assay Genie
15.1.6. Bio-Rad Laboratories, Inc.
15.1.7. Bio-Techne Corporation
15.1.8. BioAssay Systems
15.1.9. Biomedica Medizinprodukte GmbH
15.1.10. BPS Bioscience, Inc.
15.1.11. Callegari Srl
15.1.12. Cayman Chemical Company
15.1.13. Cell Biolabs, Inc.
15.1.14. Cytek Biosciences, Inc.
15.1.15. Eagle Biosciences, Inc.
15.1.16. Enzo Biochem, Inc.
15.1.17. Ethos Biosciences, Inc.
15.1.18. Geno Technology Inc.
15.1.19. Genox Corporation
15.1.20. Helvetica Health Care Sàrl
15.1.21. Hycult Biotech Inc.
15.1.22. Kamiya Biomedical Company
15.1.23. Labstat Inc.
15.1.24. Merck KGaA
15.1.25. Oxford Biomedical Research, Inc.
15.1.26. Promega Corporation
15.1.27. Qiagen N.V.
15.1.28. Thermo Fisher Scientific, Inc.
15.1.29. Vivid Microscopy, LLC
15.1.30. ZenBio, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. OXIDATIVE STRESS ASSAY MARKET RESEARCH PROCESS
FIGURE 2. OXIDATIVE STRESS ASSAY MARKET SIZE, 2022 VS 2030
FIGURE 3. OXIDATIVE STRESS ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OXIDATIVE STRESS ASSAY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. OXIDATIVE STRESS ASSAY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. OXIDATIVE STRESS ASSAY MARKET DYNAMICS
FIGURE 7. OXIDATIVE STRESS ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 8. OXIDATIVE STRESS ASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. OXIDATIVE STRESS ASSAY MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
FIGURE 10. OXIDATIVE STRESS ASSAY MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. OXIDATIVE STRESS ASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 12. OXIDATIVE STRESS ASSAY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. OXIDATIVE STRESS ASSAY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. OXIDATIVE STRESS ASSAY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. OXIDATIVE STRESS ASSAY MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 16. OXIDATIVE STRESS ASSAY MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OXIDATIVE STRESS ASSAY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES OXIDATIVE STRESS ASSAY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA OXIDATIVE STRESS ASSAY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. OXIDATIVE STRESS ASSAY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. OXIDATIVE STRESS ASSAY MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Abcam PLC
  • Agilent Technologies, Inc.
  • AMS Biotechnology
  • Arbor Assays Inc.
  • Assay Genie
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioAssay Systems
  • Biomedica Medizinprodukte GmbH
  • BPS Bioscience, Inc.
  • Callegari Srl
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Cytek Biosciences, Inc.
  • Eagle Biosciences, Inc.
  • Enzo Biochem, Inc.
  • Ethos Biosciences, Inc.
  • Geno Technology Inc.
  • Genox Corporation
  • Helvetica Health Care Sàrl
  • Hycult Biotech Inc.
  • Kamiya Biomedical Company
  • Labstat Inc.
  • Merck KGaA
  • Oxford Biomedical Research, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
  • Vivid Microscopy, LLC
  • ZenBio, Inc.

Methodology

Loading
LOADING...

Table Information